Skip to content

Impact of Medications Review on Potentially Inappropriate Medications and Clinical Outcomes Among Hospitalized Older Adults

Impact of Medications Review on Potentially Inappropriate Medications and Clinical Outcomes Among Hospitalized Older Adults: A Randomized Controlled Trial (REVMED RCT) Protocol

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05875623
Enrollment
500
Registered
2023-05-25
Start date
2023-07-06
Completion date
2025-12-30
Last updated
2025-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aged, Deprescriptions, Inappropriate Prescribing, Polypharmacy, Potentially Inappropriate Medications

Brief summary

The goal of this randomized controlled trial is to assess the effectiveness of a pharmacist-led medication review using the locally developed Malaysian Potentially Inappropriate Prescribing Screening tool in Older Adults (MALPIP), an explicit criteria in hospitalized older adults. The main questions it aims to answer are: 1. The effectiveness of the intervention in reducing the number of PIMs and chronic medications after discharge 2. The impact of the intervention on quality of life, falls events, emergency department visits, readmissions and survivals Researchers will compare the control group to see if there is corresponding changes to the outcomes specified above.

Interventions

OTHERMALPIP criteria

In the intervention group, the clinical pharmacist will apply the MALPIP criteria on all the admission and discharge medications. The intervention will consist of 4 steps: i) pharmacist review using MALPIP criteria to detect PIM, ii) discussion with doctors for deprescribing decision iii) discussion with patients and documentation of shared decision iv) follow up patients

Sponsors

Hospital Raja Permaisuri Bainun
CollaboratorOTHER_GOV
Monash University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients aged 60 years and above * Taking more than five regular drugs * Having at least one chronic medical condition * Ability to understand and speak Malay, English, or Mandarin language

Exclusion criteria

* Admitted for end-of-life care * Diagnosed with terminal illness * Diagnosed with active cancer * Participated in another drug trial * Refused or unable to give consent * Visited the Emergency Department without admission to ward * Readmitted and have been previously enrolled in the trial

Design outcomes

Primary

MeasureTime frame
Number of potentially inappropriate medicationsAdmission up to 18 months
Number of chronic medicationsAdmission up to 18 months

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026